Table of Contents for Cancer Therapies to 2009
EXECUTIVE SUMMARY
Summary Table ... 3
MARKET ENVIRONMENT
General ... 4
Economic Environment ... 5
Cyclical Trends .... 5
Table - Macroeconomic Environment ... 9
Long-Term Trends ... 9
Table - Cancer Therapies Market Trends, 1994-2004 ... 11
Chart - Cancer Therapies Market Volatility .... 12
Demographic Patterns ... 12
Table - Resident Population by Age & Sex .... 14
Health Care Environment ... 14
Health Insurance & Reimbursement .... 16
Table - Health Care Indicators ... 16
Medical Conditions ... 19
able - Medical Conditions ... 19
Acute Conditions ... 20
Chronic Conditions ... 20
Cancer Incidence & Indicators ... 21
Table - Cancer Incidences & Deaths ... 22
Chart - New Cancer Incidences by Type, 2004 ... 23
National Health Expenditures .... 23
Table - National Health Expenditures ... 26
Medical Providers ... 26
Table - Medical Providers ... 28
Pharmaceuticals Industry Overview ... 28
Biotechnology Industry Overview ... 30
Table - Pharmaceuticals & Biotechnology Market Indicators ... 30
Cost/Pricing Dynamics ... 32
Chart - Cancer Therapies Pricing Patterns, 1994-2014 ... 33
Regulatory Environment ... 33
Multinational Dynamics ... 36
World Cancer Therapies Market ... 36
Table - World Cancer Therapies Market ... 38
Trends in US Foreign Trade ... 38
Table - US Foreign Trade in Cancer Therapy Drugs ... 39
TECHNOLOGY
General ... 40
Traditional Cancer Treatments ... 42
Surgery ... 42
Radiation ... 44
Chemotherapy ... 46
Advanced Cancer Therapies ... 47
Biotechnology-Based ... 48
Cancer Vaccines ... 50
Nanotechnology-Based ... 51
Stem Cells ... 53
Chemotherapy Adjuvants ... 53
Therapy Delivery Systems ... 54
Other Technological Issues ... 55
Cancer Screening & Imaging Systems ... 56
Health Care Information Systems ... 57
PRODUCTS & SERVICES
General ... 59
Table - Cancer Therapies Demand ... 61
Therapies by Type of Cancer ... 61
Table - Therapies Demand by Type of Cancer ... 63
Chart - Cancer Therapies Demand by Type of Cancer, 2004 ... 64
Breast ... 64
Table - Breast Cancer Therapies Demand ... 66
Digestive System ... 66
Table - Digestive System Cancer Therapies Demand ... 69
Genital System ... 69
Table - Genital System Cancer Therapies Demand ... 72
Leukemia .... 72
Table - Leukemia Therapies Demand ... 74
Lymphoma ... 74
Table - Lymphoma Therapies Demand ... 76
Respiratory System ... 76
Table - Respiratory System Cancer Therapies Demand ... 79
Skin ... 79
Table - Skin Cancer Therapies Demand ... 81
Urinary System ... 81
Table - Urinary System Cancer Therapies Demand ... 83
Other ... 83
Table - Other Cancers Therapies Demand ... 85
Therapies by Product/Procedure ... 86
Table - Therapies Demand by Product/Procedure ... 88
Chart - Cancer Therapies Demand by Product/Procedure, 2004 ... 88
Chemotherapy Drugs ... 89
Table - Chemotherapy Drug Demand ... 90
Mitotic Inhibitors ... 90
Antimetabolites ... 91
Alkylating Agents ... 91
Other Types ... 92
Surgery ... 93
Table - Cancer Surgery Demand ... 95
Radiation Therapy ... 95
Table - Cancer Radiation Therapy Demand ... 98
Biotechnology-Based Drugs ... 98
Table - Biotechnology-Based Cancer Drugs Demand ...101
Other/Advanced ... 101
Table - Other/Advanced Cancer Therapies Demand ... 102
Hormonal Therapy ... 103
Vaccines ... 103
Nanotechnology ... 104
Stem Cells & Other ... 105
MARKETS General ... 107
Table - Cancer Therapies Market by Institution/Provider ... 109
Chart - Cancer Therapies Market by Institution/Provider, 2004 ...109
Hospitals ...110
Market Overview ... 110
Table - Hospital Indicators ...112
Cancer Therapies Outlook ... 112
Table - Hospital Cancer Therapies Market ... 114
Outpatient Facilities ... 114
Market Overview ... 116
Table - Outpatient Facilities Indicators ... 117
Cancer Therapies Outlook ... 118
Table - Outpatient Facilities Cancer Therapies Market ... 119
Physicians’ Offices ... 119
Market Overview ... 120
Table - Physicians Indicators ...121
Cancer Therapies Outlook ... 122
Table - Physicians’ Offices Cancer Therapies Market ... 124
Other Markets ... 124
Table - Other Cancer Therapies Markets ... 126
Home Health Care ... 126
Educational & Research Institutions ... 127
INDUSTRY STRUCTURE
General ... 130
Industry Composition & Market Share ... 131
Chart - US Cancer Therapies 2004 Market Share by Company ... 134
Research & Product Development ... 134
Table - Research & Development Spending Patterns: Selected Cancer Therapy Companies ... 136
Manufacturing ... 136
Table - Capital Spending Patterns: Selected Cancer Therapy Firms ... 138
Marketing & Distribution ... 138
Financial Issues & Requirements ... 140
Table - Composite Financial Ratios: Selected Cancer Therapy Companies, 2004 ... 142
Mergers, Acquisitions & Industry Restructuring ... 143
Table - Selected Acquisitions & Divestitures ... 144
Strategic Partnerships ... 145
Table - Selected Strategic Partnerships ... 147
Table - Revenue & Profits Data: Selected Cancer Therapy Companies, 2004 ... 154
Company Profiles Albany Molecular Research Inc. ... 156
American Pharmaceutical Partners Inc. ... 157
Amgen Incorporated ... 159
AstraZeneca plc ... 162 Biogen Idec Incorporated ... 166
Bristol-Myers Squibb Company ... 168
Cell Therapeutics Incorporated ... 172
Cephalon Incorporated ... 174
Genentech Incorporated ... 176
Genzyme Corporation ... 181
GlaxoSmithKline plc ... 184
ImClone Systems Incorporated ... 187
Johnson & Johnson ... 189 Ligand Pharmaceuticals Incorporated ... 193
Lilly (Eli) and Company ...194
Merck & Company Incorporated ... 197
MGI Pharma Incorporated ... 199
Millennium Pharmaceuticals Inc. ... 201
Novartis International AG ... 203
OSI Pharmaceuticals Incorporated ... 206
Pfizer Incorporated ... 209
Pharmion Corporation ... 212
Radiation Therapy Services Inc. ... 213
Roche Holding Limited ... 215
Sanofi-Aventis ... 218
Schering-Plough Corporation ... 222
US Oncology Incorporated ... 224
Wyeth... 226
Other Companies Mentioned in Study ... 228
CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: jenniferc@cmsinfo.com
copyright © 2005 all rights reserved
For more information about us, visit CMSinfo.
